Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Bullboard Posts
Comment by Minty_33on Sep 05, 2019 4:13pm
146 Views
Post# 30099718

RE:RE:RE:RE:RE:RE:new investors

RE:RE:RE:RE:RE:RE:new investorsI’m of the opinion that leading up to the listing on the OTCQX and start of trading, some positive news will be announced to shore up interest in the company. In the past, CZO has a history of putting out good news prior to earnings releases. Case and point, the two research grants for PGX, one just a day before the Q2 earnings release. Good on them for timing this, unfortunately the 900K injection not to mention the vote of confidence in PGX by the two organizations didn’t move the needle one iota. Nevertheless, it’s a pattern I’ve noticed and I firmly believe that an inked deal will be forthcoming sooner than later, or as  Digitel eluded to, information on the cholesterol trial,  functional food or drink. This puppy isn’t staying at these levels for too much longer IMHO. 
Bullboard Posts